Results Healthcare   |   Results International

Insights

We add value by understanding our sectors inside out, and release regular industry research and reports

Results Healthcare has provided strategic support to Horizon Therapeutics resulting in the acquisition of a facility from EirGen Pharma

By Kevin Bottomley, Kunal Kadiwar 21 Jun 2021

Horizon has acquired a drug manufacturing facility from EirGen Pharma

Results Healthcare is delighted to announce that it has provided strategic support to Horizon Therapeutics, a biotechnology company focused on rare, autoimmune diseases, that resulted in its acquisition of a drug product manufacturing facility from EirGen Pharma, in Ireland.

Under the terms of the agreement, Horizon will acquire the facility for a $65 million upfront cash payment. In addition, there is adjacent IDA land available for further manufacturing and development expansion. The transaction, which is subject to customary closing conditions, is expected to close in the third quarter.

Tim Walbert, chairman, president and chief executive officer, Horizon

Adding to our strong network of contract manufacturing organizations, this facility will also play an important role in our global expansion. We look forward to leveraging our existing technical operations expertise in Ireland, along with the expertise of the EirGen employees, to build a robust and effective manufacturing operation that will enable us to meet the unmet needs of people impacted by rare diseases around the world.

 

Our expertise in pharma & biotech

 

Kevin Bottomley

Partner

Contact Kevin

Kunal Kadiwar

Managing Director

Contact Kunal

Insights

Regular Public Healthcare Sector Analysis, News, Blogs & White Papers

View our insights     SUBSCRIBE

Connect with us

Follow Results Healthcare on Twitter Follow Results Healthcare on LinkedIn

Your Nearest Office